PubRank

Comparative Effectiveness of FITs With Colonoscopy

Clinical Trial ID NCT03264898

PubWeight™ 0.00‹?›

🔗 Visit the ClinicalTrials.gov page for NCT03264898

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Multitarget stool DNA testing for colorectal-cancer screening. N Engl J Med 2014 11.07
2 Evaluating test strategies for colorectal cancer screening: a decision analysis for the U.S. Preventive Services Task Force. Ann Intern Med 2008 6.99
3 How many endoscopies are performed for colorectal cancer screening? Results from CDC's survey of endoscopic capacity. Gastroenterology 2004 4.69
4 A quantitative immunochemical fecal occult blood test for colorectal neoplasia. Ann Intern Med 2007 3.41
5 Vital signs: colorectal cancer screening test use--United States, 2012. MMWR Morb Mortal Wkly Rep 2013 3.12
6 Preferences for colorectal cancer screening among racially/ethnically diverse primary care patients. Med Care 2008 2.48
7 Immunochemical fecal occult blood testing is equally sensitive for proximal and distal advanced neoplasia. Am J Gastroenterol 2012 1.98
8 Sensitivity, but not specificity, of a quantitative immunochemical fecal occult blood test for neoplasia is slightly increased by the use of low-dose aspirin, NSAIDs, and anticoagulants. Am J Gastroenterol 2009 1.80
9 A systematic comparison of microsimulation models of colorectal cancer: the role of assumptions about adenoma progression. Med Decis Making 2011 1.77
10 Patient preferences and adherence to colorectal cancer screening in an urban population. Am J Public Health 2006 1.48
11 Colorectal cancer screening in Europe. World J Gastroenterol 2009 1.47
12 The best screening test for colorectal cancer is the one that gets done well. Gastrointest Endosc 2010 1.38
13 Cancer screening in the United States, 2016: A review of current American Cancer Society guidelines and current issues in cancer screening. CA Cancer J Clin 2016 1.19
14 Advances in Fecal Occult Blood Tests: the FIT revolution. Dig Dis Sci 2014 0.95
15 Cumulative evaluation of a quantitative immunochemical fecal occult blood test to determine its optimal clinical use. Cancer 2010 0.93
16 Prevalence of major risk factors and use of screening tests for cancer in the United States. Cancer Epidemiol Biomarkers Prev 2015 0.91
17 Stool Testing for Colorectal Cancer Screening. Gastroenterology 2015 0.89
18 Colorectal cancer screening: 20 years of development and recent progress. World J Gastroenterol 2014 0.85
19 Comparison of patient preferences for fecal immunochemical test or colonoscopy using the analytic hierarchy process. BMC Health Serv Res 2015 0.84
20 The burden of bowel preparations in patients undergoing elective colonoscopy. United European Gastroenterol J 2015 0.83
21 Test characteristics of faecal immunochemical tests (FIT) compared with optical colonoscopy. J Med Screen 2014 0.81
22 Sensitivity and Specificity of Community Fecal Immunotesting Screening for Colorectal Carcinoma in a High-Risk Canadian Population. Arch Pathol Lab Med 2015 0.76
Next 100